Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoHempTechLabs is a biotechnology and ingredient technology company specializing in the nano-emulsification of cannabinoids to create highly bioavailable, water-soluble compounds. The company utilizes advanced ultrasonic cavitation technology to reduce cannabinoid particles to a nanometer scale, significantly enhancing absorption rates and onset times compared to traditional oil-based delivery methods. Their product portfolio includes water-soluble powders and liquid emulsions designed for seamless integration into beverages, edibles, and topical formulations. NanoHempTechLabs operates as a contract development and manufacturing organization (CDMO), providing wholesale, white-label, and private-label services to the hemp and wellness industries. By focusing on science-driven delivery systems, the company aims to standardize the efficacy and consistency of cannabinoid-infused consumer goods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoHempTechLabs.